SCHEMBL21532387

SCHEMBL21532387

c1ccc(-c2nnc(-c3ccccc3)n2-c2ccc3c(c2)c2ccccc2n3-c2ccc(-c3cccc(-n4c5ccccc5c5c6oc7ccccc7c6ccc54)c3)cc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AVPR1A P37288 1/20 0.36
ALDH1A1 P00352 4/20 0.34
TSHR P16473 2/20 0.34
HSD17B10 Q99714 2/20 0.34
MEN1 O00255 1/20 0.34
POLB P06746 1/20 0.34
BRCA1 P38398 1/20 0.34
KMT2A Q03164 1/20 0.34
KDM4E B2RXH2 2/20 0.34
ATM Q13315 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
OPRD1 P41143 2/20 0.34
SMN1; SMN2 Q16637 3/20 0.33
LMNA P02545 3/20 0.33
HPGD P15428 2/20 0.33
MAPK1 P28482 1/20 0.33
OXTR P30559 1/20 0.32
GLA P06280 1/20 0.32
ALOX5 P09917 1/20 0.31
PPARG P37231 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21532284 0.97 ALDH1A1 (0.35) AVPR1AALDH1A1TSHRHSD17B10MEN1
SCHEMBL21532291 0.96 AVPR1A (0.36) AVPR1AALDH1A1TSHRHSD17B10MEN1
SCHEMBL21532305 0.96 ALDH1A1 (0.34) AVPR1AALDH1A1TSHRHSD17B10MEN1
SCHEMBL21532546 0.95 ALDH1A1 (0.35) AVPR1AALDH1A1TSHRHSD17B10MEN1
SCHEMBL21532535 0.94 ALDH1A1 (0.35) AVPR1AALDH1A1TSHRHSD17B10MEN1
SCHEMBL21532177 0.94 ALDH1A1 (0.36) AVPR1AALDH1A1TSHRHSD17B10MEN1
SCHEMBL21532806 0.94 ALOX5 (0.35) AVPR1AALDH1A1TSHRHSD17B10MEN1
SCHEMBL21532285 0.93 ALDH1A1 (0.35) AVPR1AALDH1A1TSHRHSD17B10MEN1
SCHEMBL21532572 0.93 ALOX5 (0.35) ALDH1A1TSHRHSD17B10MEN1POLB
SCHEMBL21532393 0.92 ALDH1A1 (0.34) AVPR1AALDH1A1TSHRHSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11145825-B2 Condensed cyclic compound and organic light-emitting device including i he same SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-10-12 US disclosed
US-20190334095-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-10-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11145825-B2 Condensed cyclic compound and organic light-emitting device including i he same CRY1, CCNT1, CCNA1 AVPR1A 694/4885ALDH1A1 158/4885TSHR 3802/4885
US-20190334095-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNT1, ARL1 AVPR1A 475/4885ALDH1A1 283/4885TSHR 3504/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.